In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001
- 1 July 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (7) , 590-599
- https://doi.org/10.1046/j.1469-0691.2003.00573.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000Journal of Antimicrobial Chemotherapy, 2001
- Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal AnalysisAntimicrobial Agents and Chemotherapy, 2001
- Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United StatesAntimicrobial Agents and Chemotherapy, 2000
- Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre studyDiagnostic Microbiology and Infectious Disease, 2000
- Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in CanadaNew England Journal of Medicine, 1999
- In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogensInternational Journal of Antimicrobial Agents, 1998
- Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland.Journal of Antimicrobial Chemotherapy, 1998
- Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance studyJournal of Antimicrobial Chemotherapy, 1996
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995
- Pneumococcal resistance to antibioticsClinical Microbiology Reviews, 1990